{"id":2938,"date":"2017-08-12T11:01:57","date_gmt":"2017-08-12T11:01:57","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/?p=2938"},"modified":"2026-01-05T13:42:41","modified_gmt":"2026-01-05T13:42:41","slug":"studiu-hipertermie-locala-profunda","status":"publish","type":"post","link":"https:\/\/andromedichyperthermia.com\/ro\/studiu-hipertermie-locala-profunda\/","title":{"rendered":"\u00a0Hipertermie regional\u0103 profund\u0103 \u00een combina\u021bie cu radioterapie cerebral\u0103 integral\u0103 (WBRT) la pacien\u021bi cu prognostic slab \u0219i metastaze cerebrale"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"WebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/ro\/studiu-hipertermie-locala-profunda\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/ro\/studiu-hipertermie-locala-profunda\/\",\n      \"name\": \"Studiu Clinic: HyDeep 600WM \u0219i Radioterapia (WBRT) \u00een Metastaze Cerebrale | Andromedic\",\n      \"description\": \"Rezultatele studiului clinic prospectiv privind combinarea radioterapiei cerebrale totale (WBRT) cu hipertermia profund\u0103 Andromedic HyDeep 600WM pentru pacien\u021bii cu metastaze cerebrale.\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"inLanguage\": \"ro-RO\",\n      \"about\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" }\n      ]\n    },\n    {\n      \"@type\": \"MedicalScholarlyArticle\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/ro\/studiu-hipertermie-locala-profunda\/#article\",\n      \"headline\": \"Hipertermia regional\u0103 profund\u0103 \u00een combina\u021bie cu radioterapia cerebral\u0103 total\u0103 (WBRT) la pacien\u021bii cu prognostic rezervat \u0219i metastaze cerebrale\",\n      \"author\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/cristian-gologan\/\" }\n      ],\n      \"publisher\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"datePublished\": \"2017-08-12\",\n      \"keywords\": [\n        \"Metastaze Cerebrale\", \"Radioterapie WBRT\", \"HyDeep 600WM\", \"Scor GPA\", \"Supravie\u021buire PFS\", \"Hipertermie Local\u0103 Profund\u0103\"\n      ],\n      \"abstract\": \"Studiu prospectiv pe 15 pacien\u021bi cu 49 de metastaze cerebrale. Utiliz\u00e2nd Andromedic HyDeep 600WM la 13.56 MHz, studiul a demonstrat c\u0103 hipertermia (mHT) de \u00eenalt\u0103 calitate \u00eembun\u0103t\u0103\u021be\u0219te semnificativ PFS la 6 \u0219i 12 luni (100% \u0219i 66.7%) fa\u021b\u0103 de grupul de control.\",\n      \"mentions\": [\n        { \"@type\": \"MedicalCondition\", \"name\": \"Metastaze Cerebrale\" },\n        { \"@type\": \"MedicalTest\", \"name\": \"GPA (Graded Prognostic Assessment)\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" }\n      ]\n    },\n    {\n      \"@type\": \"MedicalStudy\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#brain-met-trial-ro\",\n      \"name\": \"Studiu Clinic HyDeep 600WM \u0219i WBRT\",\n      \"studySubject\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"studyDesign\": \"Studiu Prospectiv\",\n      \"healthCondition\": { \"@type\": \"MedicalCondition\", \"name\": \"Metastaze Cerebrale\" },\n      \"intervention\": [\n        \"Hipertermie Regional\u0103 Profund\u0103 (Andromedic HyDeep 600WM)\",\n        \"Radioterapie Cerebral\u0103 Total\u0103 (WBRT)\",\n        \"Terapie Sistemic\u0103\"\n      ],\n      \"outcome\": \"\u00cembun\u0103t\u0103\u021birea PFS la 12 luni pentru grupul cu mHT eficient (66.7% vs 0%, p<0.031) f\u0103r\u0103 toxicitate \u00eenregistrat\u0103.\"\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"Andromedic HyDeep 600 WM\",\n      \"sku\": \"HYDEEP-600WM\",\n      \"brand\": {\n        \"@type\": \"Brand\",\n        \"name\": \"Andromedic\"\n      },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/07\/advanced-modulated-RF-hyperthermia-device-Andromedic-HY-DEEP-600WM-local-oncologic-hyperthermia.jpg\",\n      \"description\": \"Dispozitiv de hipertermie locala ce opereaz\u0103 la RF 13.56 MHz (mHT), dovedit clinic pentru \u00eembun\u0103t\u0103\u021birea supravie\u021buirii f\u0103r\u0103 progresia bolii \u00een metastazele cerebrale.\",\n      \"manufacturer\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"aggregateRating\": {\n        \"@type\": \"AggregateRating\",\n        \"ratingValue\": \"4.9\",\n        \"reviewCount\": \"25\",\n        \"bestRating\": \"5\",\n        \"worstRating\": \"4\"\n      },\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/ro\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Pre\u021bul echipamentului medical este disponibil la cerere pentru clinici \u0219i centre oncologice.\"\n        }\n      }\n    },\n    {\n      \"@type\": \"Physician\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-veronica-iatan\/\",\n      \"name\": \"Dr. Veronica Iatan\",\n      \"jobTitle\": \"Co-fondator SRHO, Expert Medical\",\n      \"address\": {\n        \"@type\": \"PostalAddress\",\n        \"streetAddress\": \"Strada Stadionului 25G\",\n        \"addressLocality\": \"Clinceni\",\n        \"postalCode\": \"077060\",\n        \"addressCountry\": \"RO\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 950px; margin: auto; font-family: 'Segoe UI', Roboto, Arial, sans-serif;\">\n<div style=\"background-color: #f8f9fa; padding: 40px 20px; border-radius: 15px; border-left: 5px solid #0056b3; margin-bottom: 30px; text-align: center; box-shadow: 0 4px 12px rgba(0,0,0,0.05);\">\n<h1 style=\"color: #0056b3; font-size: 26px; line-height: 1.4; margin-bottom: 10px;\"><a style=\"text-decoration: none; color: inherit;\" href=\"http:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Deep-regional-hyperthermia-in-combination-with-whole-brain-radiotherapy-wbrt-in-poor-prognosis-patients-with-brain-metastases.pdf\"><br \/>\nHipertermie Locoregional\u0103 Profund\u0103 \u00een combina\u021bie cu Radioterapie Cerebral\u0103 Integral\u0103 (WBRT) la pacien\u021bi cu prognostic slab \u0219i <strong>Metastaze Cerebrale<\/strong><br \/>\n<\/a><\/h1>\n<h2 style=\"font-size: 18px; color: #d9534f; font-weight: 600; margin-top: 10px;\">Studiu clinic: Eficacitatea <strong>dispozitivului de hipertermie<\/strong> HyDeep 600WM<\/h2>\n<\/div>\n<div style=\"max-width: 600px; margin: 0 auto 30px auto; text-align: center;\">\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-6979 size-full\" style=\"border-radius: 8px; box-shadow: 0 4px 15px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2017\/08\/Deep-local-hyperthermia-in-combination-with-Whole-Brain-RadioTherapy-WBRT-in-Poor-Prognosis-Patients-with-Brain-Metastases.jpg\" alt=\"Studiu clinic: Eficacitatea dispozitivului de hipertermie locala profunda HyDeep 600WM in metastaze cerebrale\" width=\"567\" height=\"776\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2017\/08\/Deep-local-hyperthermia-in-combination-with-Whole-Brain-RadioTherapy-WBRT-in-Poor-Prognosis-Patients-with-Brain-Metastases.jpg 567w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2017\/08\/Deep-local-hyperthermia-in-combination-with-Whole-Brain-RadioTherapy-WBRT-in-Poor-Prognosis-Patients-with-Brain-Metastases-219x300.jpg 219w\" sizes=\"auto, (max-width: 567px) 100vw, 567px\" \/><\/p>\n<p style=\"font-style: italic; color: #555; margin-top: 15px; font-size: 14px;\"><strong>Hipertermie local\u0103 profund\u0103<\/strong> \u00een combina\u021bie cu radioterapia cerebral\u0103 integral\u0103 (WBRT) la pacien\u021bii cu prognostic slab \u0219i metastaze cerebrale.<\/p>\n<p>&nbsp;<\/p>\n<\/div>\n<h2 style=\"color: #0056b3; border-bottom: 2px solid #0056b3; padding-bottom: 10px; margin-top: 40px;\">Rezumat studiu clinic <strong>hipertermie locala profunda<\/strong> Andromedic<\/h2>\n<p><strong>Scop:<\/strong> Scopul acestui studiu clinic este de a evalua, pentru prima dat\u0103, rolul <strong>hipertermiei locoregionale profunde<\/strong> \u00een combina\u021bie cu radioterapia \u0219i terapia sistemic\u0103 la pacien\u021bii cancer cu metastaze cerebrale cu prognostic slab (GPI \u2264 2,5).<\/p>\n<p><strong>Metode:<\/strong> Pacien\u021bii oncologici cu metastaze cerebrale confirmate \u0219i clasifica\u021bi cu scor GPI \u22642,5 au fost inclu\u0219i \u00een acest studiu prospectiv. Stratificarea pretratamentului a fost definit\u0103 ca pacien\u021bi cu scor GPI 0-1 (grupa A) \u0219i pacien\u021bi cu scor GPI 1,5-2,5 (grupa B). HT a fost aplicat\u0103 de dou\u0103 ori pe s\u0103pt\u0103m\u00e2n\u0103, \u0219aizeci de minute pe sesiune, \u00een timpul radioterapiei, prin intermediul unui dispozitiv de hipertermie loco-regionala (<strong><a href=\"https:\/\/andromedichyperthermia.com\/ro\/dispozitiv-hipertermie-locala-rf-mht\/\">dispozitiv de hipertermie oncologic\u0103<\/a><\/strong> Andromedic <strong>HyDeep 600WM<\/strong>) la radiofrecven\u021b\u0103 de <strong>13,56 MHz<\/strong> (electro-hipertermie RF modulat\u0103).<\/p>\n<div style=\"background: #eef9ff; border-radius: 12px; padding: 25px; border: 1px solid #31708f; margin: 30px 0;\">\n<p><strong>Rezultate:<\/strong> \u00centre iunie 2015 \u0219i iunie 2017, 15 pacien\u021bi \u0219i un total de 49 de metastaze cerebrale au fost inclu\u0219i \u00een protocol. To\u021bi pacien\u021bii au primit toate sesiunile de HT conform planific\u0103rii. RT \u0219i terapia sistemic\u0103 au fost, de asemenea, finalizate conform prescrip\u021biei.<br \/>\n<strong>Toleran\u021ba la tratament a fost excelent\u0103 \u0219i nu s-a \u00eenregistrat nicio toxicitate. <\/strong><\/p>\n<p><strong>Pacien\u021bii cu un timp de tratament eficient al HT mai lung dec\u00e2t mediana (timp W90 &gt; 88%) au prezentat o supravie\u021buire f\u0103r\u0103 progresie (PFS) actuarial\u0103 mai bun\u0103 la 6 \u0219i 12 luni (100% \u0219i, respectiv, 66,7%) comparativ cu cei cu un timp de tratament eficient al HT mai scurt (50% \u0219i, respectiv, 0%)<\/strong> (p&lt;0,031).<\/p>\n<p>Supravie\u021buirea global\u0103 median\u0103 a fost de 6 luni (interval 1-36 luni). Stratificarea dup\u0103 scorul GPI a ar\u0103tat o supravie\u021buire global\u0103 median\u0103 de 3 luni (IC 95% 2,49-3,51) \u00een Grupa A \u0219i de 8,0 luni (IC 95% 5,15-10,41) \u00een Grupa B (p=0,035).<\/p>\n<\/div>\n<p><strong>Concluzii:<\/strong> <strong>Hipertermia locoregional\u0103 profunda<\/strong> este o tehnic\u0103 fezabil\u0103 \u0219i sigur\u0103, utilizat\u0103 \u00een combina\u021bie cu radioterapia la pacien\u021bii cu metastaze cerebrale, \u00eembun\u0103t\u0103\u021bind supravie\u021buirea f\u0103r\u0103 progresie (PFS) \u0219i supravie\u021buirea la pacien\u021bii oncologici cu metastaze cerebrale cu prognostic slab.<\/p>\n<hr style=\"margin: 40px 0; border: 0; border-top: 1px solid #eee;\" \/>\n<p>\u00cen studiul nostru au fost incluse 49 de metastaze cerebrale de la 15 pacien\u021bi care apar\u021bineau grupelor cu cea mai nefavorabil\u0103 medie a scorului (GPA): 6 pacien\u021bi cancer au avut un indice de scor de 0-1 (Grupa A) \u0219i 9 pacien\u021bi au avut un indice de scor de 1,5-2,5 (Grupa B). To\u021bi pacien\u021bii au fost trata\u021bi cu o combina\u021bie de radioterapie \u0219i <strong>mHT locoregional\u0103<\/strong>. Prima concluzie a studiului nostru este c\u0103 terapia combinat\u0103 cu RT \u0219i HT regional\u0103 este un tratament bine tolerat la pacien\u021bii cu metastaze cerebrale. Toate tratamentele au fost administrate conform prescrip\u021biilor.<\/p>\n<div style=\"background: #fff5f5; border-left: 5px solid #d9534f; padding: 20px; margin: 25px 0;\">\n<p><strong>Nu s-a \u00eenregistrat nicio toxicitate datorat\u0103 HT. \u00cen schimb, Byun \u0219i colab. [13], \u00een studiul lor cu HT intraoperator, au descris convulsiile \u0219i infec\u021bia pl\u0103gii drept complica\u021bii ale tratamentului combinat \u00eentr-un num\u0103r relevant de cazuri. Hipertermia profund\u0103 (mHT) pare a fi mai u\u0219or \u0219i mai sigur de administrat dec\u00e2t tratamentele intraoperatorii complicate.<\/strong><\/p>\n<\/div>\n<p>Calitatea tratamentului HT (W90time &gt;88%) a reprezentat cel mai puternic factor predictiv pentru supravie\u021buire. Astfel, pacien\u021bii care au beneficiat de &gt;88% din timpul de tratament la 90% din puterea prescris\u0103 (150W) au avut rate excelente de supravie\u021buire f\u0103r\u0103 progresie (PFS), recunosc\u00e2nd rolul <strong>electro-hipertermiei RF modulate<\/strong> \u00een sensibilizarea tumorilor la radiochimioterapie [4-7].<\/p>\n<div style=\"background: #d4edda; border: 1px solid #c3e6cb; padding: 30px; border-radius: 15px; text-align: center; margin-top: 30px;\">\n<p style=\"font-size: 18px; color: #155724; font-weight: bold; margin-bottom: 15px;\">Conform supravie\u021buirii generale, supravie\u021buirea general\u0103 median\u0103 a fost de 6 luni \u00een seria noastr\u0103, \u00eembun\u0103t\u0103\u021bind rezultatele slabe ale tratamentului standard \u00een aceste cazuri [3].<\/p>\n<p style=\"font-size: 16px;\">Asocierea <strong>hipertermiei oncologice<\/strong> cu tratamentul sistemic RT +\/- a atins o probabilitate de supravie\u021buire de <strong>53,1% la 6 luni<\/strong> \u0219i de <strong>30,6% la 12 luni<\/strong> la pacien\u021bii no\u0219tri cu metastaze cerebrale.<\/p>\n<hr style=\"margin: 40px 0; border: 0; border-top: 1px solid #eee;\" \/>\n<h2 style=\"color: #0056b3; text-align: center; margin-bottom: 30px;\">\u00centreb\u0103ri frecvente despre tratamentul metastazelor cerebrale prin hipertermie<\/h2>\n<div style=\"margin-bottom: 25px; border-bottom: 1px solid #eee; padding-bottom: 15px;\">\n<p style=\"font-weight: bold; color: #0056b3; margin-bottom: 8px; font-size: 17px;\">Q: Cum influen\u021beaz\u0103 hipertermia locala profund\u0103 Andromedic supravie\u021buirea \u00een cazul metastazelor cerebrale?<\/p>\n<p style=\"font-size: 16px; line-height: 1.5;\">A: Studiul prospectiv a demonstrat c\u0103 ad\u0103ugarea <strong>hipertermiei RF modulate (mHT)<\/strong> Andromedic la radioterapia cerebral\u0103 integral\u0103 (WBRT) \u00eembun\u0103t\u0103\u021be\u0219te semnificativ <strong>supravie\u021buirea f\u0103r\u0103 progresie (PFS)<\/strong>. Pacien\u021bii care au beneficiat de un termotratament oncologic eficient au \u00eenregistrat o rat\u0103 de PFS de <strong>100% la 6 luni<\/strong> \u0219i <strong>66,7% la 12 luni<\/strong>, rezultate net superioare tratamentului standard.<\/p>\n<\/div>\n<div style=\"margin-bottom: 25px; border-bottom: 1px solid #eee; padding-bottom: 15px;\">\n<p style=\"font-weight: bold; color: #0056b3; margin-bottom: 8px; font-size: 17px;\">Q: Ce reprezint\u0103 indicatorul W90time \u0219i de ce este important pentru eficacitatea dispozitivului de hipertermie locala HyDeep 600WM?<\/p>\n<p style=\"font-size: 16px; line-height: 1.5;\">A: <strong>W90time<\/strong> reprezint\u0103 timpul de tratament \u00een care se men\u021bine cel pu\u021bin 90% din puterea prescris\u0103. Studiul a concluzionat c\u0103 un indicator <strong>W90 &gt; 88%<\/strong> reprezint\u0103 cel mai puternic factor predictiv pentru supravie\u021buire, confirm\u00e2nd importan\u021ba preciziei \u0219i stabilit\u0103\u021bii oferite de tehnologia de hipertermie avansata <strong>HyDeep 600WM<\/strong> la 13,56 MHz.<\/p>\n<\/div>\n<div style=\"margin-bottom: 25px; border-bottom: 1px solid #eee; padding-bottom: 15px;\">\n<p style=\"font-weight: bold; color: #0056b3; margin-bottom: 8px; font-size: 17px;\">Q: Exist\u0103 riscuri de convulsii sau toxicitate la utilizarea hipertermiei pentru tumori cerebrale?<\/p>\n<p style=\"font-size: 16px; line-height: 1.5;\">A: Spre deosebire de metodele invazive sau intraoperatorii, <strong>hipertermia locoregional\u0103 profund\u0103 (mHT)<\/strong> cu dispozitivul HyDeep 600WM s-a dovedit a fi extrem de sigur\u0103. Pe durata studiului <strong>nu s-a \u00eenregistrat nicio toxicitate<\/strong> sau complica\u021bii neurologice (precum convulsiile), demonstr\u00e2nd o toleran\u021b\u0103 excelent\u0103 a pacien\u021bilor oncologici.<\/p>\n<p style=\"font-size: 14px; margin-bottom: 15px;\"><strong>\u00a0Referinte stiintifice:<\/strong><br \/>\n<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32748093\/\" target=\"_blank\" rel=\"noopener\">PubMed ID: 32748093<\/a> |<br \/>\n<a href=\"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02404-9\" target=\"_blank\" rel=\"noopener\">Springer Link<\/a><\/p>\n<\/div>\n<div style=\"margin-top: 25px;\"><a style=\"background-color: #155724; color: white; padding: 12px 25px; text-decoration: none; border-radius: 5px; font-weight: bold; display: inline-block;\" href=\"https:\/\/andromedichyperthermia.com\/contact\/\">Solicit\u0103 Consultan\u021b\u0103 Tehnic\u0103 pentru Clinica Ta<\/a><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Hipertermie Locoregional\u0103 Profund\u0103 \u00een combina\u021bie cu Radioterapie Cerebral\u0103 Integral\u0103 (WBRT) la pacien\u021bi cu prognostic slab \u0219i Metastaze Cerebrale Studiu clinic: Eficacitatea dispozitivului de hipertermie HyDeep 600WM Hipertermie local\u0103 profund\u0103 \u00een combina\u021bie cu radioterapia cerebral\u0103 integral\u0103 (WBRT) la pacien\u021bii cu prognostic slab \u0219i metastaze cerebrale. &nbsp; Rezumat studiu clinic hipertermie locala profunda Andromedic Scop: Scopul acestui&hellip;<\/p>\n","protected":false},"author":1,"featured_media":7051,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[19],"tags":[166,1089,1090,165,1093],"class_list":["post-2938","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized-ro","tag-andromedic-hydeep-600wm","tag-dispozitiv-de-hipertermie-oncologica","tag-electro-hipertermie-rf-modulata","tag-hipertermie-locala-profunda","tag-tratament-metastaze-cerebrale"],"gutentor_comment":0,"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/posts\/2938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/comments?post=2938"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/posts\/2938\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/media\/7051"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/media?parent=2938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/categories?post=2938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/ro\/wp-json\/wp\/v2\/tags?post=2938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}